# BioXcel Therapeutics, Inc.: Form 8-K, filed Jan 20, 2026

- Company: [BioXcel Therapeutics, Inc.](/companies/btaiq.md) (CIK 1720893)
- Form: 8-K
- Filed: 2026-01-20
- Accepted by EDGAR: Jan 20, 2026, 07:00 ET
- Period: 2026-01-20
- Accession: 0001104659-26-004787
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1720893/000110465926004787/tm263511d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1720893/000110465926004787/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1720893/000110465926004787/tm263511d1_8k.htm

Filed Jan 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-004787. Last ingested by Listed: Oct 30, 2026, 17:24 ET. No prices; not investment advice.